Related references
Note: Only part of the references are listed.p21-Activated protein kinases and their emerging roles in glucose homeostasis
Yu-ting Alex Chiang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)
TGFβR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressiveness
Xiaoming Lyu et al.
MOLECULAR CANCER (2014)
Myosin Heads Are Displaced from Actin Filaments in the In Situ Beating Rat Heart in Early Diabetes
Mathew J. Jenkins et al.
BIOPHYSICAL JOURNAL (2013)
MicroRNA Deregulation in Right Ventricular Outflow Tract Myocardium in Nonsyndromic Tetralogy of Fallot
Jin Zhang et al.
CANADIAN JOURNAL OF CARDIOLOGY (2013)
Diabetic cardiomyopathy: pathophysiology and clinical features
Takayuki Miki et al.
HEART FAILURE REVIEWS (2013)
Nebivolol Induces Distinct Changes in Profibrosis MicroRNA Expression Compared With Atenolol, in Salt-Sensitive Hypertensive Rats
Hongmei Ye et al.
HYPERTENSION (2013)
MiR-30-Regulated Autophagy Mediates Angiotensin II-Induced Myocardial Hypertrophy
Wei Pan et al.
PLOS ONE (2013)
The Prevention of Diabetic Cardiomyopathy by Non-Mitogenic Acidic Fibroblast Growth Factor Is Probably Mediated by the Suppression of Oxidative Stress and Damage
Chi Zhang et al.
PLOS ONE (2013)
Cytoskeletal role in protection of the failing heart by β-adrenergic blockade
Guangmao Cheng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2012)
A phenotypic screen to identify hypertrophy-modulating microRNAs in primary cardiomyocytes
Claudia Jentzsch et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Enhanced activation of p21-activated kinase 1 in heart failure contributes to dephosphorylation of connexin 43
Xun Ai et al.
CARDIOVASCULAR RESEARCH (2011)
Pak1 as a Novel Therapeutic Target for Antihypertrophic Treatment in the Heart
Wei Liu et al.
CIRCULATION (2011)
Ablation of p21-activated kinase-1 in mice promotes isoproterenol-induced cardiac hypertrophy in association with activation of Erk1/2 and inhibition of protein phosphatase 2A
Domenico M. Taglieri et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
miR133a regulates cardiomyocyte hypertrophy in diabetes
Biao Feng et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2010)
Role of Differential Signaling Pathways and Oxidative Stress in Diabetic Cardiomyopathy
Kenichi Watanabe et al.
CURRENT CARDIOLOGY REVIEWS (2010)
miR-133 and miR-30 Regulate Connective Tissue Growth Factor Implications for a Role of MicroRNAs in Myocardial Matrix Remodeling
Rudy F. Duisters et al.
CIRCULATION RESEARCH (2009)
Cdc42 is an antihypertrophic molecular switch in the mouse heart
Marjorie Maillet et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Regulation of Akt/PKB activity by P21-activated kinase in cardiomyocytes
Kai Mao et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Regulation of cardiac excitation and contraction by p21 activated kinase-1
Yunbo Ke et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2008)
MicroRNAs are aberrantly expressed in hypertrophic heart - Do they play a role in cardiac hypertrophy?
Yunhui Cheng et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
MicroRNA-133 controls cardiac hypertrophy
Alessandra Care et al.
NATURE MEDICINE (2007)
Cdc42 plays a critical role in assembly of sarcomere units in series of cardiac myocytes
T Nagai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Hyperglycemia inhibits capacitative calcium entry and hypertrophy in neonatal cardiomyocytes
Y Pang et al.
DIABETES (2002)
Tissue-specific GATA factors are transcriptional effectors of the small GTPase RhoA
F Charron et al.
GENES & DEVELOPMENT (2001)
The mechanism of PAK activation - Autophosphorylation events in both regulatory and kinase domains control activity
C Chong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Regulation of mitogen-activated protein kinases in cardiac myocytes through the small G protein Rac1
A Clerk et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Small guanine nucleotide-binding proteins and myocardial hypertrophy
A Clerk et al.
CIRCULATION RESEARCH (2000)
Share Paper
